Banner
Global CRISPR And Cas Gene Market Report 2024

CRISPR And Cas Gene Global Market Report 2024 – By Product Type (Kits And Enzymes, Libraries, Design Tool, Antibodies, Other Products Types), By Service Type (Cell Line Engineering, gRNA Design, Microbial Gene Editing, DNA Synthesis), By Application (Clinical, Financial, Operational And Administrative), By End Use (Biotechnology And Pharmaceutical Companies, Academics And Government Research Institutes, Contract Research Organizations (CROs)) – Market Size, Trends, And Global Forecast 2024-2033

CRISPR And Cas Gene Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
CRISPR And Cas Gene Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN

CRISPR And Cas Gene Market Definition

CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, and the Cas (CRISPR-associated) gene, particularly Cas9, constitute a powerful gene-editing technology. This system enables precise modifications to DNA sequences, revolutionizing genetic research, biotechnology, and potential medical applications.

The main product types of CRISPR and Cas genes include kits and enzymes, libraries, design tools, antibodies, and others. Kits and enzymes constitute essential components in the area of CRISPR-based gene therapy, with kits including the ingredients and instruments required for gene editing research and enzymes, such as Cas9, playing an important part in the gene editing process. The services are categorized into cell line engineering, gRNA design, microbial gene editing, and DNA synthesis and are used in applications such as clinical, financial, operational, and administrative by end users such as biotechnology and pharmaceutical companies, academic and government research institutes, and contract research organizations (CROs).

CRISPR And Cas Gene Market Segmentation

The crispr and cas gene market covered in this report is segmented –

1) By Product Type: Kits And Enzymes, Libraries, Design Tool, Antibodies, Other Products Types

2) By Service Type: Cell Line Engineering, gRNA Design, Microbial Gene Editing, DNA Synthesis

3) By Application: Clinical, Financial, Operational And Administrative

4) By End Use: Biotechnology And Pharmaceutical Companies, Academics And Government Research Institutes, Contract Research Organizations (CROs)

Global CRISPR And Cas Gene Market Size 2023 to 2028: Graph

CRISPR And Cas Gene Market Size 2024 And Growth Rate

The crispr and cas gene market size has grown exponentially in recent years. It will grow from $3.28 billion in 2023 to $3.97 billion in 2024 at a compound annual growth rate (CAGR) of 21.3%. The growth in the historic period can be attributed to increased consumer awareness, shift in consumer values, rise in celebrity endorsements, rise of veganism, increased social media influence.

CRISPR And Cas Gene Market Growth Forecast

The crispr and cas gene market size is expected to see exponential growth in the next few years. It will grow to $8.37 billion in 2028 at a compound annual growth rate (CAGR) of 20.5%. The growth in the forecast period can be attributed to global expansion of bans, rising conscious consumerism, emergence of new brands, consumer education initiatives, beauty inclusivity. Major trends in the forecast period include technology advancements, product innovations, circular beauty economy, men's grooming segment, social justice and ethical sourcing.

CRISPR And Cas Gene Market Driver: Personalized Therapy Driving Surge In CRISPR And Cas Gene Market Growth

A growing focus on personalized therapy is expected to propel the growth of the CRISPR and Cas gene markets going forward. Personalized therapy refers to a medical model that uses an individual's genetic profile to guide decisions made concerning the diagnosis, treatment, and prevention of disease. CRISPR and the Cas gene, particularly Cas9, are used in personalized medicine, enabling precise modifications to an individual's genetic material and holding promise for breakthroughs in developing tailored therapies for genetic disorders, cancer, and various medical conditions. For instance, in January 2023, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Out of the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the rising demand for personalized therapy will drive the growth of the CRISPR and Cas gene markets.

Global CRISPR And Cas Gene Market Major Players

Major companies operating in the crispr and cas gene market report are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc, AstraZeneca plc., Danaher Corporation, Quest Diagnostics, Lonza Group AG, Bio-Rad Laboratories Inc., eGenesis, Novartis Institutes for BioMedical Research, Myriad Genetics Inc., GenScript, Takara Bio Inc., 23andMe Inc., Merck KGaA, Color Genomics Inc., Horizon Discovery Group Plc, Beam Therapeutics Inc, Intellia Therapeutics Inc., New England BioLabs, Recursion Pharmaceuticals Inc, Caribou Biosciences Inc., Cellectis S.A., Editas Medicine Inc.

Global CRISPR And Cas Gene Market Trend: CRISPR-Based Cell-Based Gene Therapy Revolutionizes Treatment Landscape In The CRISPR And Cas Gene Market

Major companies operating in the CRISPR and Cas gene markets are developing innovative products such as CRISPR-based cell-based gene therapy to enhance product offerings and gain a competitive advantage. CRISPR-based cell-based gene therapy involves using the CRISPR gene-editing technology to modify or correct genetic material within cells, offering a targeted and potentially revolutionary approach to treating genetic disorders, diseases, and other medical conditions at the cellular level. For instance, in December 2023, Vertex Pharmaceuticals Incorporated, a US-based biopharmaceutical company, received approval for CASGEVY (exagamglogene autotemcel [exa-cel]) from the U.S. Food and Drug Administration (FDA). CASGEVY is a CRISPR/Cas9 genome-edited gene therapy for the management of sickle cell disease (SCD) in individuals aged 12 and above who have recurrent vaso-occlusive crises. CASGEVY is a first-of-its-kind medication that has the potential to be a one-time transformational therapy for qualified sickle cell patients. CASGEVY administration necessitates specific training in stem cell transplantation, hence, Vertex is collaborating with experienced institutions to create a network of independently owned, approved treatment centers (ATCs) across the United States to provide CASGEVY to patients.

CRISPR And Cas Gene Market Merger And Acquisition: Bayer AG and Mammoth Biosciences Forge Collaboration To Advance Next-Gen CRISPR Products In Gene Therapy

In January 2022, Bayer AG, a Germany-based pharmaceutical company, collaborated with Mammoth Biosciences to leverage the richness of nature in advancing the next generation of CRISPR products. The partnership aims to utilize Mammoth's CRISPR systems for the development of in vivo gene-editing therapies. This agreement enhances Bayer's emerging cell and gene therapy platform and aligns with Mammoth's vision of unlocking the complete potential of innovative CRISPR systems. Mammoth BioSciences is a US-based biotechnology company that develops CRISPR-Cas gene diagnostic tests.

Regional Insights For The Global CRISPR And Cas Gene Market

North America was the largest region in the CRISPR and Cas gene market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the crispr and cas gene market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the CRISPR and Cas gene market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The CRISPR and Cas gene market consists of revenues earned by entities by offering services such as gene editing, targeted disruption of genes, targeted drug development, livestock breeding, and animal model construction. The market value includes the value of related goods sold by the service provider or included within the service offering. The CRISPR and Cas gene market also includes sales of RNA clean-up kits, phenol-free kits, t7 polymerase mix, and RNAse-free water. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The CRISPR and Cas gene research report is one of a series of new reports from The Business Research Company that provides CRISPR and Cas gene market statistics, including the CRISPR and Cas gene industry's global market size, regional shares, competitors with a CRISPR and Cas gene market share, detailed CRISPR and Cas gene market segments, market trends and opportunities, and any further data you may need to thrive in the CRISPR and Cas gene industry. This CRISPR and Cas gene market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

CRISPR And Cas Gene Market Report Forecast and Analysis
Report AttributeDetails
Market Size Value In 2024 $3.97 billion
Revenue Forecast In 2033 $8.37 billion
Growth Rate CAGR of 20.5% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product Type: Kits And Enzymes, Libraries, Design Tool, Antibodies, Other Products Types
2) By Service Type: Cell Line Engineering, gRNA Design, Microbial Gene Editing, DNA Synthesis
3) By Application: Clinical, Financial, Operational And Administrative
4) By End Use: Biotechnology And Pharmaceutical Companies, Academics And Government Research Institutes, Contract Research Organizations (CROs)
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc; AstraZeneca plc.; Danaher Corporation; Quest Diagnostics; Lonza Group AG; Bio-Rad Laboratories Inc.; eGenesis; Novartis Institutes for BioMedical Research; Myriad Genetics Inc.; GenScript; Takara Bio Inc.; 23andMe Inc.; Merck KGaA; Color Genomics Inc.; Horizon Discovery Group Plc; Beam Therapeutics Inc; Intellia Therapeutics Inc.; New England BioLabs; Recursion Pharmaceuticals Inc; Caribou Biosciences Inc.; Cellectis S.A.; Editas Medicine Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. CRISPR And Cas Gene Market Characteristics

    3. CRISPR And Cas Gene Market Trends And Strategies

    4. CRISPR And Cas Gene Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global CRISPR And Cas Gene Market Size and Growth

    5.1. Global CRISPR And Cas Gene Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global CRISPR And Cas Gene Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global CRISPR And Cas Gene Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. CRISPR And Cas Gene Market Segmentation

    6.1. Global CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Kits And Enzymes

    Libraries

    Design Tool

    Antibodies

    Other Products Types

    6.2. Global CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Cell Line Engineering

    gRNA Design

    Microbial Gene Editing

    DNA Synthesis

    6.3. Global CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Clinical

    Financial

    Operational And Administrative

    6.4. Global CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Biotechnology And Pharmaceutical Companies

    Academics And Government Research Institutes

    Contract Research Organizations (CROs)

    7. CRISPR And Cas Gene Market Regional And Country Analysis

    7.1. Global CRISPR And Cas Gene Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global CRISPR And Cas Gene Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific CRISPR And Cas Gene Market

    8.1. Asia-Pacific CRISPR And Cas Gene Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China CRISPR And Cas Gene Market

    9.1. China CRISPR And Cas Gene Market Overview

    9.2. China CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India CRISPR And Cas Gene Market

    10.1. India CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan CRISPR And Cas Gene Market

    11.1. Japan CRISPR And Cas Gene Market Overview

    11.2. Japan CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia CRISPR And Cas Gene Market

    12.1. Australia CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia CRISPR And Cas Gene Market

    13.1. Indonesia CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea CRISPR And Cas Gene Market

    14.1. South Korea CRISPR And Cas Gene Market Overview

    14.2. South Korea CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe CRISPR And Cas Gene Market

    15.1. Western Europe CRISPR And Cas Gene Market Overview

    15.2. Western Europe CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK CRISPR And Cas Gene Market

    16.1. UK CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany CRISPR And Cas Gene Market

    17.1. Germany CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France CRISPR And Cas Gene Market

    18.1. France CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy CRISPR And Cas Gene Market

    19.1. Italy CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain CRISPR And Cas Gene Market

    20.1. Spain CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe CRISPR And Cas Gene Market

    21.1. Eastern Europe CRISPR And Cas Gene Market Overview

    21.2. Eastern Europe CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia CRISPR And Cas Gene Market

    22.1. Russia CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America CRISPR And Cas Gene Market

    23.1. North America CRISPR And Cas Gene Market Overview

    23.2. North America CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA CRISPR And Cas Gene Market

    24.1. USA CRISPR And Cas Gene Market Overview

    24.2. USA CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada CRISPR And Cas Gene Market

    25.1. Canada CRISPR And Cas Gene Market Overview

    25.2. Canada CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America CRISPR And Cas Gene Market

    26.1. South America CRISPR And Cas Gene Market Overview

    26.2. South America CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil CRISPR And Cas Gene Market

    27.1. Brazil CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East CRISPR And Cas Gene Market

    28.1. Middle East CRISPR And Cas Gene Market Overview

    28.2. Middle East CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa CRISPR And Cas Gene Market

    29.1. Africa CRISPR And Cas Gene Market Overview

    29.2. Africa CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. CRISPR And Cas Gene Market Competitive Landscape And Company Profiles

    30.1. CRISPR And Cas Gene Market Competitive Landscape

    30.2. CRISPR And Cas Gene Market Company Profiles

    30.2.1. F. Hoffmann-La Roche AG

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Thermo Fisher Scientific Inc

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. AstraZeneca plc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Danaher Corporation

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Quest Diagnostics

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. CRISPR And Cas Gene Market Other Major And Innovative Companies

    31.1. Lonza Group AG

    31.2. Bio-Rad Laboratories Inc.

    31.3. eGenesis

    31.4. Novartis Institutes for BioMedical Research

    31.5. Myriad Genetics Inc.

    31.6. GenScript

    31.7. Takara Bio Inc.

    31.8. 23andMe Inc.

    31.9. Merck KGaA

    31.10. Color Genomics Inc.

    31.11. Horizon Discovery Group Plc

    31.12. Beam Therapeutics Inc

    31.13. Intellia Therapeutics Inc.

    31.14. New England BioLabs

    31.15. Recursion Pharmaceuticals Inc

    32. Global CRISPR And Cas Gene Market Competitive Benchmarking

    33. Global CRISPR And Cas Gene Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The CRISPR And Cas Gene Market

    35. CRISPR And Cas Gene Market Future Outlook and Potential Analysis

    35.1 CRISPR And Cas Gene Market In 2028 - Countries Offering Most New Opportunities

    35.2 CRISPR And Cas Gene Market In 2028 - Segments Offering Most New Opportunities

    35.3 CRISPR And Cas Gene Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global CRISPR And Cas Gene Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global CRISPR And Cas Gene Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: F. Hoffmann-La Roche AG Financial Performance
  • Table 76: Thermo Fisher Scientific Inc Financial Performance
  • Table 77: AstraZeneca plc. Financial Performance
  • Table 78: Danaher Corporation Financial Performance
  • Table 79: Quest Diagnostics Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global CRISPR And Cas Gene Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global CRISPR And Cas Gene Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global CRISPR And Cas Gene Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, CRISPR And Cas Gene Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, CRISPR And Cas Gene Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, CRISPR And Cas Gene Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: F. Hoffmann-La Roche AG Financial Performance
  • Figure 76: Thermo Fisher Scientific Inc Financial Performance
  • Figure 77: AstraZeneca plc. Financial Performance
  • Figure 78: Danaher Corporation Financial Performance
  • Figure 79: Quest Diagnostics Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the CRISPR and cas gene market?

CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, and the Cas (CRISPR-associated) gene, particularly Cas9, constitute a powerful gene-editing technology. This system enables precise modifications to DNA sequences, revolutionizing genetic research, biotechnology, and potential medical applications. For further insights on the CRISPR and cas gene market, request a sample here

How will the CRISPR and cas gene market drivers and restraints affect the CRISPR and cas gene market dynamics? What forces will shape the CRISPR and cas gene industry going forward?

The CRISPR and cas gene market major growth driver - personalized therapy driving surge in CRISPR and cas gene market growth. For further insights on the CRISPR and cas gene market, request a sample here

What is the forecast market size or the forecast market value of the CRISPR and cas gene market ?

The CRISPR and cas gene market size has grown exponentially in recent years. It will grow from $3.28 billion in 2023 to $3.97 billion in 2024 at a compound annual growth rate (CAGR) of 21.3%. The growth in the historic period can be attributed to increased consumer awareness, shift in consumer values, rise in celebrity endorsements, rise of veganism, increased social media influence. The CRISPR and cas gene market size is expected to see exponential growth in the next few years. It will grow to $8.37 billion in 2028 at a compound annual growth rate (CAGR) of 20.5%. The growth in the forecast period can be attributed to global expansion of bans, rising conscious consumerism, emergence of new brands, consumer education initiatives, beauty inclusivity. Major trends in the forecast period include technology advancements, product innovations, circular beauty economy, men's grooming segment, social justice and ethical sourcing. For further insights on the CRISPR and cas gene market, request a sample here

How is the CRISPR and cas gene market segmented?

The CRISPR and cas gene market is segmented
1) By Product Type: Kits And Enzymes, Libraries, Design Tool, Antibodies, Other Products Types
2) By Service Type: Cell Line Engineering, gRNA Design, Microbial Gene Editing, DNA Synthesis
3) By Application: Clinical, Financial, Operational And Administrative
4) By End Use: Biotechnology And Pharmaceutical Companies, Academics And Government Research Institutes, Contract Research Organizations (CROs)For further insights on the CRISPR and cas gene market,
request a sample here

Which region has the largest share of the CRISPR and cas gene market? What are the other regions covered in the report?

North America was the largest region in the CRISPR and Cas gene market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR and cas gene market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the CRISPR and cas gene market, request a sample here.

Who are the major players in the CRISPR and cas gene market?

Major companies operating in the CRISPR and cas gene market report are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc, AstraZeneca plc., Danaher Corporation, Quest Diagnostics, Lonza Group AG, Bio-Rad Laboratories Inc., eGenesis, Novartis Institutes for BioMedical Research, Myriad Genetics Inc., GenScript, Takara Bio Inc., 23andMe Inc., Merck KGaA, Color Genomics Inc., Horizon Discovery Group Plc, Beam Therapeutics Inc, Intellia Therapeutics Inc., New England BioLabs, Recursion Pharmaceuticals Inc, Caribou Biosciences Inc., Cellectis S.A., Editas Medicine Inc. For further insights on the CRISPR and cas gene market, request a sample here.

What are the key trends in the CRISPR and cas gene market?

Major trend in the CRISPR and cas gene market - crispr-based cell-based gene therapy revolutionizes treatment landscape in the CRISPR and cas gene market. For further insights on the CRISPR and cas gene market, request a sample here.

What are the major opportunities in the CRISPR and cas gene market? What are the strategies for the CRISPR and cas gene market?

For detailed insights on the major opportunities and strategies in the CRISPR and cas gene market, request a sample here.

How does the CRISPR and cas gene market relate to the overall economy and other similar markets?

For detailed insights on CRISPR and cas gene market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the CRISPR and cas gene industry?

For detailed insights on the mergers and acquisitions in the CRISPR and cas gene industry, request a sample here.

What are the key dynamics influencing the CRISPR and cas gene market growth? SWOT analysis of the CRISPR and cas gene market.

For detailed insights on the key dynamics influencing the CRISPR and cas gene market growth and SWOT analysis of the CRISPR and cas gene industry, request a sample here.